Thomas Anderton Joins Squire Patton Boggs in San Francisco

By Press Releases
January 16, 2017

Tom Anderton

Tom Anderson

Thomas Anderton has joined the Intellectual Property & Technology Practice at Squire Patton Boggs as of counsel in San Francisco. Mr. Anderton has extensive life sciences experience, with a particular focus on biopharma IP portfolios.  Mr. Anderton joins the firm from Zonare Medical Systems, an ultrasound solutions company, where he was General Counsel and Secretary with responsibility for the company’s legal and business strategy with a strong emphasis on IP protection, portfolio management and transactions.

Before joining Zonare, he was Vice President of Intellectual Property and Legal Affairs at Presidio Pharmaceuticals Inc., a specialty pharmaceutical company focusing on the hepatitis C virus, and previously Associate General Counsel and Chief Patent Counsel at Monogram Biosciences Inc., where he was responsible for the IP portfolio, which was widely recognized as being industry-leading. Earlier in his career, he was Lead Attorney for Healthcare at Genencor, Inc. where he developed and implemented the company’s life sciences and healthcare IP portfolio.

“Squire Patton Boggs has an outstanding Intellectual Property team and I’m delighted to be able to further enhance the firm’s already outstanding life science practice,” Mr. Anderton said. “From my time leading in-house legal teams, I have a deep appreciation for the firm’s expertise, culture and international outlook. I look forward to joining Squire Patton Boggs’ California team while working across their global platform for the benefit of our multinational pharmaceutical and healthcare clients.”

David Elkins, global leader of the Intellectual Property & Technology Practice at the firm, commented: “Tom brings a wealth of IP portfolio creation, management, monetization and transactional experience in life sciences and the healthcare industries, particularly biologics, to our Intellectual Property & Technology Practice. Given our breadth of life science and healthcare clients, as well as intellectual property expertise, Tom’s arrival brings even greater depth to our client service capabilities in those areas.”

The Intellectual Property & Technology Practice has made a number of key appointments and promotions in 2016. The firm recently added a five-lawyer brand management team in Frankfurt; a data privacy and cybersecurity expert in Brussels; and promoted two lawyers to partner in Palo Alto and London respectively. In the Life Sciences Industry Group, Leah Brownlee re-joined the firm in October as of counsel from Cleveland BioLabs Inc, where she served as Executive Vice President of Compliance and Operations and Corporate Secretary.

Mr. Anderton studied Molecular Biology at the University of California at San Diego and Cancer Biology at Stanford University. He received his Juris Doctor from Vermont Law School. He is a member of the State Bar of California and is registered to practice before the United States Patent and Trademark Office.

About Squire Patton Boggs

Squire Patton Boggs is one of the world’s strongest integrated legal practices. With 46 offices in 21 countries, the firm is renowned for its local connections and global influence, delivering comprehensive legal services across North America, Europe, the Middle East, Asia Pacific and Latin America. With expertise spanning all key sectors, the firm is also known for its preeminent Public Policy Practice and deep-rooted relationships in Washington DC and Brussels.

The Author

Press Releases

Press Releases : Industry news brought to you by IPWatchdog.com

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com. Read more.

Discuss this

There are currently No Comments comments.